FDA Recall Watch | McIntyre Law PC
Teva recalls US-made drugs following contamination fears - The Boston Globe
/cloudfront-us-east-1.images.arcpublishing.com/gray/UVAUY3N3VBKKPJZ24MSVDZL62I.png "FDA recalls blood pressure medicine due to potential cancer risk")
FDA recalls blood pressure medicine due to potential cancer risk
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | FDA
Teva Pharmaceuticals announces recall of two blood pressure drugs.
Overview of the FDA's Drug-Recall Process
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure
Teva Stops Production At US Plant After FDA Concerns: Report
2 high blood pressure medications added to recall of heart drug - ABC News
FDA recalls blood pressure medicine due to potential cancer risk
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
More Blood Pressure Drugs Recalled Due to Potential Cancer Risk | Moffitt
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply | Fierce Pharma
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Pharma Receive Warning Letter - Parker Waichman LLP
Teva's troubled Godollo plant earns firm US FDA warning letter
Teva Pharma Recalls One Lot Of Anagrelide Capsules
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Dissolution Test Failure Prompts Recall of Anagrelide Capsules - MPR
Metformin recall by FDA: What's the latest news on metformin ER?
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
FDA recall expands for heart drug with possible cancer-causing impurity
Government of the Virgin Islands - High Blood Pressure Treatment Drug Valsartan Recalled Healthcare professionals and patients are being advised of a voluntary recall of products containing the active pharmaceutical ingredient (API)
Vegas doctor explains blood pressure med recall
